NEW YORK (GenomeWeb News) – Verinata Health has tapped Noah Nasser, Suzanne Yokota, and Xitong Li to develop its fetal diagnostic testing business.
Nasser, who formerly was a business unit manager for molecular diagnostics at Quidel Corporation, will be Verinata's VP of sales and market development. Yokota, who will be Verinata's new VP of marketing and commercial operations, started with the company last year and formerly was commercial director at Satoris, and she held several management posts at Affymetrix. Li, who will be Verinata's director of bioinformatics, was associate director of bioinformatics at Genomic Health, and he worked at Ingenuity Systems and Novartis.
The University of Arizona has appointed Shane Burgess to be the new dean of its College of Agricultural and Life Sciences. Burgess currently is director of the Institute for Genomics, Biocomputing, and Biotechnology at Mississippi State University.
Randal Kaufman has been named director of the Degenerative Disease Research Program at Sanford-Burnham Medical Research institute in its Del E. Webb Neuroscience, Aging, and Stem Cell Research Center. Kaufman previously was a professor and Howard Hughes Medical Research Institute investigator at the University of Michigan Medical School and his research has involved gene amplification and expression in mammalian cells.
Robert McBurney this week was named CEO of the Accelerated Cure Project for Multiple Sclerosis. Formerly the CEO of Cambridge Neuroscience, McBurney has held senior positions at firms including BG Medicine and TheraGenetics and is the co-founder of Differential Proteomics and Optimal Medicine.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.